This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Organic Sales to Boost Church & Dwight's (CHD) Q2 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2019 results are likely to gain from organic sales growth and prudent pricing moves.
What's in the Offing for Mondelez's (MDLZ) Q2 Earnings?
by Zacks Equity Research
Mondelez's (MDLZ) Q2 earnings to gain from saving efforts. However, high input costs and adverse currency rates are concerns.
Things You Need to Know Before AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) is poised for growth in second-quarter 2019, owing to strong sales trend and persistent strength in global brands. However, weakness in some markets and soft beer volume may affect results.
Check Out Colgate's (CL) Probability to Beat in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) growth efforts indicate that it will likely retain the robust bottom-line surprise trend. However, soft margins and adverse currency may be deterrents.
Colgate's (CL) Growth Efforts Well on Track Amid Soft Margins
by Zacks Equity Research
Colgate's (CL) strong surprise trend, higher pricing, strong innovation and expansion efforts bode well. However, high input costs and currency headwinds concerns.
Soap & Cleaning Materials Industry Outlook Upbeat on New Products
by Rajani Lohia
The FMCG space is likely to gain from investment in brands, innovation, cost-containment and pricing actions. However, its struggles against higher raw material and transportation costs continue.
3 Reasons Why Church & Dwight (CHD) Is a Hot Investment Pick
by Zacks Equity Research
Church & Dwight (CHD) is gaining on the back of strong organic sales trend, buyouts, focus on international business, product innovations and portfolio expansion.
Clorox (CLX) Stock Loses Sheen: What's Hindering its Growth?
by Zacks Equity Research
Clorox (CLX) expects gross margin to be flat in fiscal 2019 as gains from higher prices and cost-savings efforts are likely to be offset by higher costs and adverse currency rates.
Church & Dwight Sales to Gain on International Unit & More
by Zacks Equity Research
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
Why Is Church & Dwight (CHD) Up 0.3% Since Last Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike
by Zacks Equity Research
Clorox (CLX) enhances shareholder returns by a 10% hike in its quarterly dividend.
4 Factors That Make Church & Dwight (CHD) a Promising Stock
by Zacks Equity Research
Church & Dwight (CHD) is committed toward boosting gross margin through pricing. Also, it boasts a splendid sales surprise history.
Energizer (ENR) Lags Q2 Earnings, Trims View, Stock Down
by Zacks Equity Research
Energizer (ENR) posts dismal results in second-quarter fiscal 2019. Nevertheless, the company's top line is gaining from robust acquisitions.
Clorox (CLX) Down 6% in 6 Months: Can Efforts Aid Recovery?
by Zacks Equity Research
Clorox (CLX) is grappling with elevated commodity costs, adverse currency rates as well as increased manufacturing and logistics expenses. Nevertheless, the company is on track with its 2020 Strategy.
Procter & Gamble (PG) Surges 47% in a Year: More Room to Run?
by Zacks Equity Research
Procter & Gamble (PG) stock reflects immense growth potential, backed by ongoing initiatives to improve productivity. However, strained margins and currency headwinds remain deterrents.
Church & Dwight (CHD) Q1 Earnings Beat, Organic Sales Up
by Zacks Equity Research
Church & Dwight's (CHD) earnings and sales improve in Q1. Management raises net sales view, considering the buyout of FLAWLESS.
Church & Dwight (CHD) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 6.06% and 0.41%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Q3 Earnings & Sales Miss Estimates, Stock Down
by Zacks Equity Research
Clorox's (CLX) top and bottom lines missed the Zacks Consensus Estimate in third-quarter fiscal 2019. The company narrows its guidance for fiscal 2019.
Can Cost Inflation Weigh on Tyson Foods' (TSN) Q2 Earnings?
by Zacks Equity Research
Tyson Foods (TSN) Q1 results to gain from strength in chicken and beef categories. However, rising input costs and sluggish pork unit are concerns.
TESSCO (TESS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
TESSCO (TESS) is actively pursuing strategies to capitalize on exciting growth opportunities in the marketplace, which is likely to drive its fiscal fourth-quarter results.
Factors Likely to Influence Energizer's (ENR) Earnings in Q2
by Zacks Equity Research
Energizer Holdings (ENR) remains focused on core business and seeks to drive productivity to improve performance in Q2. It is also making efforts to drive top-line growth backed by its auto care business.
Medifast's (MED) Q1 Earnings to Gain From OPTAVIA Brands
by Zacks Equity Research
Sturdy growth in the OPTAVIA banner is likely to boost Medifast's (MED) Q1 results. However, rising freight and SG&A expenses are concerns.
Colgate (CL) Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Colgate's (CL) investments in brands, higher pricing and strong innovation along with expansion in new markets and channels bode well. Also, the company is on track with its savings program.
Will Chicken Woes Linger in Pilgrim's Pride (PPC) Q1 Earnings?
by Zacks Equity Research
Pilgrim's Pride (PPC) Q1 results is likely to be hurt by volatility in commodity chicken market. Nevertheless, strength in the Prepared Food unit bodes well.
Here's What You Should Note Ahead of Funko (FNKO) Q1 Earnings
by Zacks Equity Research
Funko (FNKO) is likely to benefit from strong domestic and international demand in Q1. However, costs related to fulfilling the rising demand may pressurize margins.